Percutaneous Microwave Ablation potential minimal invasive treatment of Uterine Fibroids, suggests study

Results: Out of 1,068 initial records, 14 studies comprising 754 patients with symptomatic uterine fibroids were included. There was a significant reduction in symptom severity (WMD = –33.3; 95 %CI: −41.16, −25.46; p < 0.001; I2 = 99 %) and fibroid volume (WMD = −89.26 cm3; 95 % CI: −130.64, −47.87; p < 0.01; I2 = 99 %)., along with a significant improvement in quality of life (WMD = 27.21; 95 % CI:21.70,32.72; p < 0.01; I2 = 91 %) and hemoglobin concentration (WMD = 3.20 g/dl; 95 %CI:2.71,3.69; p < 0.01;I2 = 83 %). Subgroup analysis identified study location as a significant moderator for fibroid volume reduction, with Asian studies showing a greater decrease than European studies.

The analysis suggests that PMWA therapy is an efficacious treatment for uterine fibroids, with consistent outcomes in both Asian and European populations. However, high heterogeneity among the included studies limits the interpretation of results.

Reference:

Farooq Ahmad, Ayesha Islam Khan, Aiza Asif, Sophia Ahmed, Mudasar Nisar, Eman Fatima, Faryal Khan, Anza Razzaq, Asma Tahir, Abdur Rehman Khalid, Muhammad Azeemuddin. Clinical efficacy of percutaneous microwave ablation in treating uterine fibroids: A comprehensive systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2025, 113954, ISSN 0301-2115, https://doi.org/10.1016/j.ejogrb.2025.113954.